Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kyu Yong Choi
Comparison of the Clinical Outcomes Between Antiviral-Naïve Patients Treated With Entecavir and Lamivudine-Resistant Patients Receiving Adefovir Add-On Lamivudine Combination Treatment
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
The Temporary Placement of Covered Self-Expandable Metal Stents to Seal Various Gastrointestinal Leaks After Surgery
Gut and Liver
Hepatology
Gastroenterology
Related publications
Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil
Gut
Gastroenterology
Lamivudine Plus Adefovir Combination Therapy Versus Entecavir Monotherapy for Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Virology Journal
Virology
Infectious Diseases
Impact of Lamivudine Plus Adefovir Therapy in Chronic Hepatitis B Iranian Patients, Resistant to Lamivudine Treatment Alone, on Disease Inhibition: A Pilot Study
Open Journal of Gastroenterology
Erratum To: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Digestive Diseases and Sciences
Physiology
Gastroenterology
The Efficacy of Adefovir Dipivoxil Monotherapy and the Incidence of Genotypic Resistance to Adefovir Dipivoxil in Patients With Lamivudine-Resistant Chronic Hepatitis B Infection
The Korean Journal of Hepatology
Comparison of the Efficacies and Safety of Combined Therapy Between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients With Hepatitis B Virus Infection in Real-World Practice
PLoS ONE
Multidisciplinary
Tenofovir (TDF) Has Stronger Antiviral Effect Than Adefovir (ADV) Against Lamivudine (LAM)-resistant Hepatitis B Virus (HBV)
Hepatology International
Hepatology
Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy
Hepatology International
Hepatology
Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients With or Without HIV Infection
HIV Clinical Trials
